We are live on ! Find out more
QOP

Quinn Opportunity Partners Portfolio holdings

AUM $1.92B
1-Year Est. Return 31.26%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+31.26%
3 Year Est. Return
+67.23%
5 Year Est. Return
+49.99%
10 Year Est. Return
+245.23%
AUM
$2.37B
AUM Growth
+$959M
Cap. Flow
+$955M
Cap. Flow %
40.29%
Top 10 Hldgs %
35.28%
Holding
421
New
90
Increased
94
Reduced
62
Closed
52

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$152M
2
NFLX icon
Netflix
NFLX
+$69.4M
3
HOLX
Hologic
HOLX
+$50.7M
4
EXAS
Exact Sciences
EXAS
+$48.7M
5
JHG
Janus Henderson
JHG
+$43.6M

Top Sells

Rank Stock Value
1
PGRE
Paramount Group
PGRE
+$16M
2
CYTK icon
Cytokinetics
CYTK
+$14.7M
3
ECHO
EchoStar
ECHO
+$13.2M
4
FICO icon
Fair Isaac
FICO
+$12.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$10.6M

Sector Composition

Rank Sector Weight
1 Communication Services 31.86%
2 Consumer Discretionary 15.78%
3 Healthcare 11.2%
4 Technology 10.25%
5 Consumer Staples 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDOT icon
301
Green Dot
GDOT
$744M
$390K 0.02%
+30,457
New +$378K
GRSD
302
Grandstand Limited Ordinary Shares
GRSD
$66.3M
$372K 0.02%
68,212
+20,000
+41% +$127K
TREX icon
303
Trex
TREX
$4.88B
$372K 0.02%
+10,600
New +$429K
INTC icon
304
Intel
INTC
$493B
$369K 0.02%
+10,000
New +$378K
MAT icon
305
Mattel
MAT
$4.18B
$359K 0.02%
18,070
+774
+4% +$15K
SPT icon
306
Sprout Social
SPT
$611M
$338K 0.01%
+30,000
New +$324K
TREE icon
307
LendingTree
TREE
$447M
$333K 0.01%
6,263
-1,538
-20% -$86.2K
UNH icon
308
UnitedHealth
UNH
$372B
$330K 0.01%
1,000
– –
HRL icon
309
CALL
Hormel Foods
HRL
$13.6B
$327K 0.01%
13,800
-197,000
-93% -$4.6M
TAP icon
310
CALL
Molson Coors Class B
TAP
$7.85B
$327K 0.01%
7,000
-8,500
-55% -$392K
NTAP icon
311
NetApp
NTAP
$39.3B
$323K 0.01%
3,020
– –
JILL icon
312
J. Jill
JILL
$280M
$316K 0.01%
23,000
– –
GOOG icon
313
Alphabet (Google) Class C
GOOG
$4.33T
$314K 0.01%
1,000
– –
VIR icon
314
Vir Biotechnology
VIR
$1.51B
$307K 0.01%
50,976
– –
SSP icon
315
E.W. Scripps
SSP
$331M
$305K 0.01%
+76,470
New +$257K
AVDL
316
DELISTED
Avadel Pharmaceuticals
AVDL
$302K 0.01%
14,028
-4,972
-26% -$96.5K
EXPE icon
317
Expedia Group
EXPE
$37.1B
$283K 0.01%
+1,000
New +$247K
IOVA icon
318
Iovance Biotherapeutics
IOVA
$2.86B
$259K 0.01%
95,000
-65,000
-41% -$150K
MSOS icon
319
AdvisorShares Pure US Cannabis ETF
MSOS
$900M
$258K 0.01%
54,588
-266,489
-83% -$1.19M
TACT icon
320
Transact Technologies
TACT
$54.8M
$257K 0.01%
64,288
– –
CVV icon
321
CVD Equipment Corp
CVV
$56.9M
$255K 0.01%
82,544
– –
SANA icon
322
Sana Biotechnology
SANA
$1.01B
$245K 0.01%
60,100
-60,000
-50% -$269K
HHH icon
323
Howard Hughes
HHH
$3.96B
$239K 0.01%
3,000
-8,588
-74% -$711K
QURE icon
324
uniQure
QURE
$3.21B
$239K 0.01%
10,000
-97,600
-91% -$3.77M
HRTX icon
325
Heron Therapeutics
HRTX
$69.4M
$228K 0.01%
175,344
– –
11 12
13
14 15

Similar funds

RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

Quinn Opportunity Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Quinn Opportunity Partners held 421 positions worth $2.37B, up 68% from $1.41B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Quinn Opportunity Partners deployed $955M of net new capital in Q4 2025, opening 90 new positions and adding to 94 existing holdings. Its largest new stake was Hologic: 693,600 shares worth $51.7M.

By sector, the portfolio is most concentrated in Communication Services at 32% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Cytokinetics, an estimated $14.7M trimmed.

  • Quinn Opportunity Partners's largest Q4 2025 buy was Hologic: 693,600 shares worth $51.7M.
  • Quinn Opportunity Partners added most to Electronic Arts in Q4 2025, an estimated $152M increase.
  • Quinn Opportunity Partners's biggest Q4 2025 reduction was Cytokinetics, cutting an estimated $14.7M.
  • Quinn Opportunity Partners fully exited Paramount Group in Q4 2025, selling an estimated $16M.
  • Quinn Opportunity Partners's ten largest holdings make up 35% of its $2.37B portfolio in Q4 2025.
  • Quinn Opportunity Partners opened 90 new positions and closed 52 in Q4 2025.
  • Quinn Opportunity Partners's portfolio value rose 68% quarter-over-quarter to $2.37B.

Based on Quinn Opportunity Partners's 13F filing for Q4 2025, filed 13 Feb 2026.